Yabao Pharmaceutical Group Co (SHSE:600351) Cyclically Adjusted FCF per Share: ¥0.47 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600351 Yabao Pharmaceutical Group Co Ltd SHSE:600351
67 GF Score
Price ¥6.88
GF Value ¥5.72
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Yabao Pharmaceutical Group Co Cyclically Adjusted FCF per Share?

Yabao Pharmaceutical Group Co SHSE:600351 -0.43% 67 Cyclically Adjusted FCF per Share is ¥0.47 as of Jun. 2026. GuruFocus rates SHSE:600351 with a GF Score™ of 67/100 and a GF Value™ of ¥5.72 (Modestly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Yabao Pharmaceutical Group Co's adjusted free cash flow per share for the three months ended in Jun. 2026 was ¥0.232. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.47 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Yabao Pharmaceutical Group Co's average Cyclically Adjusted FCF Growth Rate was 17.50% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 21.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 34.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Yabao Pharmaceutical Group Co was 132.10% per year. The lowest was 0.00% per year. And the median was 21.60% per year.

As of today (2026-08-04), Yabao Pharmaceutical Group Co's current stock price is ¥6.88. Yabao Pharmaceutical Group Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was ¥0.47. Yabao Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF of today is 14.64.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Yabao Pharmaceutical Group Co was 294.50. The lowest was 12.39. And the median was 27.69.


Yabao Pharmaceutical Group Co  (SHSE:600351) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Yabao Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=6.88/0.47
=14.64

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Yabao Pharmaceutical Group Co was 294.50. The lowest was 12.39. And the median was 27.69.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Yabao Pharmaceutical Group Co Cyclically Adjusted FCF per Share Related Terms


Yabao Pharmaceutical Group Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Yabao Pharmaceutical Group Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yabao Pharmaceutical Group Co Cyclically Adjusted FCF per Share Chart

Yabao Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.25 0.31 0.37 0.45

Yabao Pharmaceutical Group Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.42 0.45 0.46 0.47

SHSE:600351 vs ZTS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Yabao Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yabao Pharmaceutical Group Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yabao Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Yabao Pharmaceutical Group Co's Cyclically Adjusted Price-to-FCF falls into.


SHSE:600351
67GF Score
Yabao Pharmaceutical Group Co Ltd SHSE:600351
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yabao Pharmaceutical Group Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Yabao Pharmaceutical Group Co's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.232/116.0564*116.0564
=0.232

Current CPI (Jun. 2026) = 116.0564.

Yabao Pharmaceutical Group Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.039 102.400 0.044
201612 -0.161 102.600 -0.182
201703 -0.023 103.200 -0.026
201706 -0.029 103.100 -0.033
201709 0.060 104.100 0.067
201712 0.071 104.500 0.079
201803 0.065 105.300 0.072
201806 0.298 104.900 0.330
201809 0.023 106.600 0.025
201812 0.071 106.500 0.077
201903 0.006 107.700 0.006
201906 0.125 107.700 0.135
201909 0.081 109.800 0.086
201912 0.224 111.200 0.234
202003 0.104 112.300 0.107
202006 0.114 110.400 0.120
202009 0.034 111.700 0.035
202012 0.163 111.500 0.170
202103 0.114 112.662 0.117
202106 0.237 111.769 0.246
202109 -0.084 112.215 -0.087
202112 0.170 113.108 0.174
202203 0.043 114.335 0.044
202206 0.169 114.558 0.171
202209 0.040 115.339 0.040
202212 0.272 115.116 0.274
202303 0.095 115.116 0.096
202306 0.172 114.558 0.174
202309 0.065 115.339 0.065
202312 0.185 114.781 0.187
202403 0.366 115.227 0.369
202406 0.079 114.781 0.080
202409 0.038 115.785 0.038
202412 0.122 114.893 0.123
202503 0.183 115.116 0.184
202506 0.239 114.907 0.241
202509 0.174 115.471 0.175
202512 0.158 115.832 0.158
202603 0.256 116.303 0.255
202606 0.232 116.056 0.232

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.47 mean?
Yabao Pharmaceutical Group Co (SHSE:600351) has a Cyclically Adjusted FCF per Share of ¥0.47 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Yabao Pharmaceutical Group Co and its competitors.
Is Yabao Pharmaceutical Group Co's Cyclically Adjusted FCF per Share too high?
Yabao Pharmaceutical Group Co's current Cyclically Adjusted FCF per Share is ¥0.47. Overall, Yabao Pharmaceutical Group Co has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Yabao Pharmaceutical Group Co's Cyclically Adjusted FCF per Share compare to ZTS?
Yabao Pharmaceutical Group Co's Cyclically Adjusted FCF per Share of ¥0.47 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Yabao Pharmaceutical Group Co and its competitors. Yabao Pharmaceutical Group Co's current Cyclically Adjusted FCF per Share is ¥0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yabao Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Yabao Pharmaceutical Group Co (SHSE:600351) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥5.72, compared to a current price of ¥6.88 — trading 20.3% above its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.47. Yabao Pharmaceutical Group Co's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Yabao Pharmaceutical Group Co (SHSE:600351), the current Cyclically Adjusted FCF per Share is ¥0.47 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yabao Pharmaceutical Group Co (SHSE:600351) Overvalued in 2026?

Based on GuruFocus' analysis, Yabao Pharmaceutical Group Co stock appears to be overvalued. The current stock price of ¥6.88 is trading 20.3% above its estimated GF Value™ of ¥5.72. GuruFocus considers Yabao Pharmaceutical Group Co to be Modestly Overvalued.

Key valuation signals for SHSE:600351:

  • Cyclically Adjusted FCF per Share: ¥0.47
  • GF Value™: ¥5.72 vs. price of ¥6.88 (20.3% above fair value)
  • GF Score™: 67/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600351 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Yabao Pharmaceutical Group Co Business Description

Address No.43 Fumin Road, Ruicheng, Shanxi Province, Yuncheng, CHN, 044602
Yabao Pharmaceutical Group Co Ltd is engaged in the manufacture and operation of western and Chinese medicines, APIs, health care products, packing materials for medicine, and also engages in the planting and processing of medicinal herbs.
67GF Score

Get the complete analysis for SHSE:600351

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.88
Price
¥5.72
GF Value